Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG

Not Applicable

Terminated

• Conditions: Diabetes
• Interventions: Device: ;Accu-Chek Compact Plus LCM bulk Japan

• Registration Number: NCT01820169
• Lead Sponsor: Hoffmann-La Roche

Brief Summary

This clinical study is to determine if the use of structured testing, which is a blood glucose monitoring, via the Accu-Chek 360° View blood glucose analysis tool has a positive effect on the subjects overall glycemic control.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-03-11
• Study First Submitted QC: 2013-03-25
• Study First Posted: 2013-03-28
• Study Start: 2013-04
• Primary Completion: 2013-12
• Study Completion: 2013-12
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-02
• Last Update Posted: 2016-09-05

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

1. Age:= and >20 years. 2. Intend to paticipate in this study after education of structured testing. 3.HbA1c:= and >7.5% in the recect 2 months.

Exclusion Criteria

1.Pregancy. 2. Heavy complication 3. judged unsuitable by doctor

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Single arm	;Accu-Chek Compact Plus LCM bulk Japan	-

Primary Outcome Measures

Name	Time	Method
Improvement in HbA1c in 6 months	6 months

Secondary Outcome Measures

Name	Time	Method
4. Occurance of sever hypoglycemia.	Baseline to 6 months
1. Comparison with historical control in HbA1c change.	Baseline to 6 months
5. Doctor's opinion for Accu-Chek 360° View.	Baseline to 6 months
3. Change in BMI.	Baseline to 6 months
2. Change in blood gulucose.	Baseline to 6 months